Discover 1,307 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,307
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: Columbus OH, Cincinnati OH, Fort Wayne IN,
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Active & Responsive
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: Columbus OH, Philadelphia PA, Lebanon NH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04165798
Recruiting
Active & Responsive
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
for
Depression, Anxiety, Major Depressive Disorder
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 21 - 65
Code: NCT06820723
Phase 2, Recruiting
Active & Responsive
Study to Refine the Effectiveness of New Generation Therapies for Suicide
for
Suicide Risk, Suicide Attempt, Treatment Response
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT07818889
Recruiting
Active & Responsive
Anxiety Skills Study
for
Anxiety, Anxiety Acute, Anxiety Chronic,
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT07774481
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
for
Healthy
Location: Columbus OH, Springfield MO, Kansas City MO, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 12 - 30
Code: NCT06655324
Phase 1, Recruiting
Active & Responsive
A Study of V132 in Healthy Older Participants (V132-001)
for
Healthy
Location: Columbus OH, Springfield MO, East Greenwich RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07712575
Phase 1, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Columbus OH, Indianapolis IN, DuBois PA, Burke VA,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase 2, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Columbus OH, Cincinnati OH, Richmond IN, Westlake OH,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
for
COPD, Chronic Obstructive Pulmonary Disease
Location: Columbus OH, Pittsburgh PA, Detroit MI, DuBois PA,
Sponsor: Nuvaira, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07051707
Recruiting
Active & Responsive
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase 3, Recruiting
Active & Responsive
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
for
Exocrine Pancreatic Insufficiency
Location: Columbus OH, Pittsburgh PA, Chicago IL, Los Angeles CA
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT06477159
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression